Home » Topics » BioWorld Science

BioWorld Science
RSS

European Commission approves expanded indication for Xgeva

April 3, 2018

Pharmacokinetics of anti-HIV agent GS-9131 explored in phase I study

April 3, 2018

Catalyst submits NDA for Firdapse for LEMS

April 3, 2018

FDA grants orphan drug designation to Scholar Rock's SRK-015 for SMA

April 3, 2018

Insmed submits NDA for ALIS for nontuberculous mycobacterial lung disease

April 3, 2018

Shanghai Pharmaceuticals initiates phase Ia trial with B-001 in patients with NHL

April 3, 2018

GSK initiates phase II study of SARM GSK-2881078 in patients with COPD

April 3, 2018

NIAID initiates phase I study of HIV-1 vaccines

April 3, 2018

FN-1501 identified as a novel FLT-3 and CDK inhibitor for the treatment of AML

April 3, 2018

C4X licenses orexin-1 receptor antagonist C4X-3256 to Indivior

March 29, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...